DK3573630T3 - Forebyggelse og behandling af skader eller sygdom i knogler og brusk - Google Patents

Forebyggelse og behandling af skader eller sygdom i knogler og brusk Download PDF

Info

Publication number
DK3573630T3
DK3573630T3 DK18703531.6T DK18703531T DK3573630T3 DK 3573630 T3 DK3573630 T3 DK 3573630T3 DK 18703531 T DK18703531 T DK 18703531T DK 3573630 T3 DK3573630 T3 DK 3573630T3
Authority
DK
Denmark
Prior art keywords
cartilage
bones
disease
prevention
damage
Prior art date
Application number
DK18703531.6T
Other languages
English (en)
Inventor
Christina Uvebrant
Jan Talts
Åkerlund Evy Lundgren
Original Assignee
Xintela Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xintela Ab filed Critical Xintela Ab
Application granted granted Critical
Publication of DK3573630T3 publication Critical patent/DK3573630T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
DK18703531.6T 2017-01-27 2018-01-29 Forebyggelse og behandling af skader eller sygdom i knogler og brusk DK3573630T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762451372P 2017-01-27 2017-01-27
PCT/EP2018/052104 WO2018138322A1 (en) 2017-01-27 2018-01-29 Prevention and treatment of bone and cartilage damage or disease

Publications (1)

Publication Number Publication Date
DK3573630T3 true DK3573630T3 (da) 2021-06-07

Family

ID=61168072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18703531.6T DK3573630T3 (da) 2017-01-27 2018-01-29 Forebyggelse og behandling af skader eller sygdom i knogler og brusk

Country Status (17)

Country Link
US (2) US11517593B2 (da)
EP (2) EP3919064A1 (da)
JP (1) JP7210829B2 (da)
KR (1) KR102580320B1 (da)
CN (1) CN110234329A (da)
AU (1) AU2018211504B2 (da)
BR (1) BR112019013508A2 (da)
CA (1) CA3050099C (da)
DK (1) DK3573630T3 (da)
ES (1) ES2870776T3 (da)
IL (1) IL266772B (da)
LT (1) LT3573630T (da)
MX (1) MX388960B (da)
PL (1) PL3573630T3 (da)
PT (1) PT3573630T (da)
SG (1) SG11201904535VA (da)
WO (1) WO2018138322A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3065816T3 (en) 2017-06-07 2026-05-08 Regeneron Pharma Compositions and methods for internalizing enzymes
CN112040985A (zh) 2018-02-07 2020-12-04 瑞泽恩制药公司 用于递送治疗性蛋白质的方法和组合物
BR112020023145A2 (pt) 2018-05-17 2021-02-02 Regeneron Pharmaceuticals, Inc. anticorpo anti-cd63 ou fragmento de ligação ao antígeno do mesmo, molécula de ligação ao antígeno biespecífica, proteína terapêutica de múltiplos domínios, polinucleotídeo composição farmacêutica, e, composto
WO2021092199A1 (en) * 2019-11-08 2021-05-14 Kansas State University Research Foundation Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
CN112941021A (zh) * 2020-03-13 2021-06-11 深圳市第二人民医院(深圳市转化医学研究院) 一种骨关节炎关节液来源的间充质干细胞的培养方法
KR20230008159A (ko) 2020-05-07 2023-01-13 신텔라 에이비 호흡기 장애의 치료를 위한 줄기세포
CN113667635A (zh) * 2020-05-14 2021-11-19 梦芊科技知识产权有限公司 无异源培养基及使用其扩增间充质干细胞的方法
CN112430269B (zh) * 2021-01-28 2021-04-20 中赛干细胞基因工程有限公司 一种促进脐带血干细胞成骨分化的组合物及其应用
IL308538A (en) 2021-05-20 2024-01-01 Xintela Ab Mesenchymal stem cells for use in the treatment of skin defects
JP2024542455A (ja) * 2021-11-15 2024-11-15 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ インビトロで活性化されたエフェクター細胞での組織再生
CN116555176B (zh) * 2022-01-28 2024-10-01 北京达尔文细胞生物科技有限公司 一种神经修复蛋白组合物及其制备方法和其应用
CN114540298A (zh) * 2022-03-25 2022-05-27 北京瑷格干细胞科技有限公司 一种干细胞无血清培养基及其制备方法
JP2025532327A (ja) * 2022-10-05 2025-09-29 ブリム バイオテクノロジー インク 骨・軟骨再生のためのｐｅｄｆ由来短鎖ペプチドと間葉系幹細胞を含む組成物
CN115651076B (zh) * 2022-12-09 2023-09-29 北京大学口腔医学院 人骨髓间充质干细胞来源凋亡囊泡的表面标志物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353061T5 (es) * 2000-04-25 2014-04-07 Osiris Therapeutics, Inc. Reparación de articulaciones utilizando células madre mesenquimatosas
EP1990350A1 (en) 2002-06-14 2008-11-12 Cartela R&D AB Marker for mesenchymal stem cells and its use
SE0301087D0 (sv) * 2003-04-14 2003-04-14 Cartela Ab New monoclonal antibody
EP1996698A1 (en) * 2006-03-01 2008-12-03 Cartela R&D AB Expansion and differentiation of mesenchymal stem cells
EP2097106A2 (en) 2006-12-15 2009-09-09 Xintela AB (SE) Novel uses and methods
EP2192908A4 (en) * 2007-07-25 2010-09-01 Bioe Inc DIFFERENTIATION OF PRECURSOR CELLS OF MULTIPLE ABSTRACTS AGAINST CHONDROCYTES

Also Published As

Publication number Publication date
EP3919064A1 (en) 2021-12-08
EP3573630A1 (en) 2019-12-04
ES2870776T3 (es) 2021-10-27
LT3573630T (lt) 2021-05-25
US20200038449A1 (en) 2020-02-06
US11517593B2 (en) 2022-12-06
JP2020505916A (ja) 2020-02-27
KR20190107686A (ko) 2019-09-20
MX388960B (es) 2025-03-20
IL266772A (en) 2019-07-31
EP3573630B1 (en) 2021-03-17
MX2019008872A (es) 2019-09-18
PL3573630T3 (pl) 2021-09-13
BR112019013508A2 (pt) 2020-01-07
JP7210829B2 (ja) 2023-01-24
CN110234329A (zh) 2019-09-13
SG11201904535VA (en) 2019-08-27
CA3050099C (en) 2024-04-16
PT3573630T (pt) 2021-05-06
AU2018211504B2 (en) 2022-08-18
KR102580320B1 (ko) 2023-09-19
US20230128397A1 (en) 2023-04-27
CA3050099A1 (en) 2018-08-02
WO2018138322A1 (en) 2018-08-02
IL266772B (en) 2022-04-01
AU2018211504A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
DK3676285T3 (da) Vaccine til anvendelse i profylakse og/eller behandling af en sygdom
IL266772B (en) Prevention and treatment of bone and cartilage damage or disease
DK3328317T3 (da) Tilbagetrækning og/eller understøttelse af periurethralt væv
PT3694529T (pt) Proteínas triespecíficas e métodos de utilização
SI3661954T1 (sl) Muteini interlevkina-21 in postopki zdravljenja
IL258706A (en) Ametropia treatment tracking methods and system
DK3432899T3 (da) Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis
DK3746126T3 (da) Fremgangsmåder og sammensætninger til behandling af søvnapnø eller simpel snorken
DK3294142T3 (da) System og fremgangsmåde af biologiske vævsstrukturer
PL3294345T3 (pl) Formulacje tpp1 i sposoby leczenia choroby cln2
EP3376977A4 (en) RECOVERY AND PROCESSING OF HUMAN EMBRYOS MADE IN VIVO
DK3692009T3 (da) Biocementationsfremgangsmåde og system
DK3174559T3 (da) Radiomærkede antistoffragmenter til anvendelse inden for forebyggelsen og/eller behandlingen af cancer
DK3287078T3 (da) Fremgangsmåde til behandling af morfologi- og elasticitetsinformation af væv og elasticitetsdetekteringsindretning
DK3444010T3 (da) Pklr-inhibering i behandlingen af nafld og hcc
DK3364915T3 (da) Medicinsk indretning til registrering og/eller stimulering af væv
IL263988B (en) Compositions useful in the prevention and/or treatment of osteoarticular inflammation and pain and cartilage damage
DK3212247T3 (da) Kirurgiske implantater til erstatning af brystvorte og areola eller beskadiget epidermis
DK3722291T3 (da) Indolinonforbindelser og deres anvendelse i behandlingen af fibrotiske sygdomme
DK3519411T3 (da) Heterocykliske forbindelser og deres anvendelse inden for forebyggelsen eller behandlingen af bakterieinfektioner
KR101868694B9 (ko) 뼈 고정 스크류 장치 및 그 체결방법
EP3655518A4 (en) ADIPOUS TISSUE DIGESTION SYSTEM AND TISSUE TREATMENT METHOD
DK3352752T3 (da) Påvisning og behandling af væksthormonmangel
EP3576527B1 (en) CRYOPROVERTY AND TISSUE RECOVERY DEVICES
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri